A Note From Our CEO & Founder
"In today’s life sciences and healthcare landscape, securing investment, scaling innovation, and delivering value require more than scientific excellence. They demand strategic clarity and flawless execution. As companies navigate complex pipelines, shifting investor expectations, and fast-moving market dynamics, the ability to operationalize change at pace becomes the true differentiator.
ClarityNorth Partners was built to meet that challenge head-on.
We go beyond helping you tell your story. We help you make it investable. From early growth through exit and expansion, our mission is to turn breakthrough science into credible, scalable businesses that investors and strategics understand, value, and back."
— Sebastian Andersen
​
Sebastian Andersen is a senior voice in the strategy, M&A, and transformation space with over a decade of experience guiding leading life sciences and healthcare companies across the full corporate lifecycle.
His work spans biopharma, medtech, advanced therapies, tools and services, healthcare delivery, and specialty chemicals, where he has partnered with corporate and private equity clients to deliver landmark transactions and strategic growth initiatives in Europe and the Americas.
​
He has advised on investor readiness programs, portfolio strategy, divestitures, integrations, and commercialization models. Known for his pragmatic, hands-on approach, Sebastian is a frequent voice on bridging science and capital, building organizations post-deal, and unlocking hidden value through operational and strategic transformation.
About ClarityNorth Partners
At ClarityNorth Partners, we believe that success in M&A and transformation doesn’t end at the signing table. It’s earned through disciplined execution, strategic clarity, and alignment across people, process, and purpose. We’re an independent advisory firm built for buyers, sellers, and investors in life sciences and healthcare, where real value is created by how well you execute throughout the company lifecycle.
Founded in New York City with global experience, we work closely with private equity teams, corporate M&A leaders, founders, and management teams navigating complex transitions across biopharma, medtech, advanced therapies, tools and services, healthcare, and specialty chemicals. Our engagements span the full lifecycle of these companies, from early-stage growth and capital raises to exits, divestitures, integrations, and strategic transformations.
Senior-led and impact-driven, every engagement is delivered by professionals who’ve been inside deals, managed operations day-to-day, and delivered tangible results. From carve-outs to integrations, governance redesign to cultural alignment, we help our clients move with purpose beyond signing and closing. We don’t just advise. We are here to help your company and your science come to life.
Depth Where It Counts. Experience That Delivers.
At ClarityNorth Partners, our work is driven by the experience and judgment of our advisors. Our team brings together strategic, transaction, and scientific expertise across the life sciences and healthcare sector.
​
Our advisors include Executive Strategy & M&A Advisors, Senior Strategy & M&A Advisors, and Scientific Advisors. Our advisors hold Executive MBA degrees, MDs, and PhDs and have built careers across venture capital, corporate development, strategic advisory, and industry leadership roles. Collectively, our team brings years of experience supporting companies through capital raises, partnerships, operational scale-ups, and strategic transactions.​
Sebastian Andersen
CEO & Founder
Sebastian Andersen is the Founder of ClarityNorth Partners and an advisor focused on strategy, capital markets, and M&A in life sciences and healthcare. He works with founders, boards, and investors on capital raising, strategic partnerships, and transactions, helping companies position themselves for growth, investment, or exit.
Victor Dong, MD, SFMBA
Executive Strategy and M&A Advisor
Dr. Dong is a Harvard trained physician specialist and MIT Sloan Fellows MBA 2026 with clinical expertise in Internal Medicine, Nephrology, Transplant Immunology and a distinguished career in global drug development at Novartis. His passion lies at the intersection of life sciences and healthcare venture capital, AI, and entrepreneurship.
Omar Abbas, MD
Senior Strategy and M&A Advisor
Dr. Abbas is a physician with expertise in precision medicine, oncology diagnostics, and digital health. He combines clinical experience in Pathology with advisory work across life sciences strategy, venture capital diligence and strategic build-up, and transactions.
Emily Thomas
Senior Strategy and M&A Advisor
Emily is an advisor focused on strategy and operations across growth-stage companies. She brings experience translating strategic priorities into operational execution, leading cross-functional initiatives, aligning leadership teams, and supporting organizations as they scale.
Nikola Gostovic
Senior Strategy and M&A Advisor
Nikola is an advisor focused on strategy, transactions, and growth across life sciences and healthcare. He brings experience from investment, corporate strategy, and advisory roles, supporting companies and investors on capital strategy, partnerships, and strategic positioning.
Our Ecosystem, Network, and Extended Bench
ClarityNorth Partners is deeply embedded in the global life sciences and healthcare investment ecosystem. Our network spans the full spectrum of subsectors, including biopharma, medtech, advanced therapies, tools and services, healthcare, and specialty chemicals.
​
We work across every major investor category, from venture capital, private equity, and family offices to corporate and strategic investors, institutional investors, and sovereign or government funds. Our reach also extends to buyers and acquirers as well as non-traditional capital partners such as incubators, accelerators, innovation hubs, and impact funds.
​
By bridging science and capital, we give our clients, whether they are in a pre-clinical discovery stage or are mature and commercial companies, access to a diverse ecosystem of investors and partners, helping them accelerate growth, scale innovation, and unlock long-term value.
Why ClarityNorth Partners
Companies that understand true deal value lies in preparation and hands-on execution, and that this demands senior-level attention to make a lasting impact, choose ClarityNorth Partners.
As your partner, we’re driven by six core principles that shape how we operate and how we deliver results. These principles are more than values. They’re how we execute, how we collaborate, and how we lead change in every engagement.
Clarity in Execution
We bring structure to complexity and force clear priorities early. Our work is designed to eliminate ambiguity so management teams can focus on the decisions that actually move value.
Respect the People Side
Transactions and capital events are change events. We understand the human, leadership, and trust dynamics that sit beneath execution, and manage them deliberately.
Operate at Pace
We move with urgency, not noise. We help teams make fast, informed decisions under pressure without losing control or strategic discipline.
Precision Over Polish
We prioritize accuracy, judgment, and usability over buzzwords and presentation gloss. Our work is built to withstand scrutiny from investors, boards, and counterparties.
Think Like Owners
We think in terms of outcomes, not deliverables. We treat capital, time, and credibility as scarce resources and act accordingly, aligning every decision to long-term value creation, not short-term optics.
Build for Day 2, Not Just Day 1
We design strategies and processes that hold up after the announcement. Our focus is on integration, separation, scale, and durability and not just getting a deal or round done.